A DC-specific cytolytic T lymphocyte line is OKT8+1

Area of Science:

• Immunology
• Cell Biology

Background:

• Cytotoxic T lymphocytes (CTLs) play a crucial role in adaptive immunity.
• Dendritic cells (DCs) are key antigen-presenting cells that initiate T cell responses.
• Understanding T cell specificity is vital for immunotherapy and vaccine development.

Purpose of the Study:

• To characterize the specificity of a human CTL line (A9) for dendritic cells (DCs).
• To identify the surface markers and antigens involved in DC recognition by CTLs.

Main Methods:

• Generation of a human CTL line (A9) via limiting dilution.
• Phenotypic characterization using monoclonal antibodies (mAbs) like OKT3, OKT4, and OKT8.
• Negative selection to isolate specific CTL subsets.
• Inhibition assays using anti-DC1, anti-DC subgroup, anti-HLA-DR, anti-OKT3, anti-LFA-2, OKT4, and OKT8 mAbs.

Main Results:

• The A9 CTL line, after negative selection, consists entirely of OKT8+ CTLs.
• These OKT8+ CTLs are inhibited by anti-DC1 and Leu-10 (anti-DC subgroup) mAbs.
• Recognition is not inhibited by anti-HLA-DR mAbs.
• CTL recognition is inhibited by anti-OKT3 and anti-LFA-2 mAbs, but not by OKT4 or OKT8 mAbs.

Conclusions:

• A specific subset of OKT8+ human cytotoxic T lymphocytes recognizes dendritic cells.
• The recognition pathway involves molecules targeted by anti-DC1 and anti-DC subgroup antibodies.
• Findings suggest the involvement of an as-yet-undefined T cell surface molecule in DC recognition, distinct from HLA-A,B, HLA-DR, and SB antigens.